Bumper Offer - Urjas oil Just @ Rs. 1
Lipisafe F is an allopathic medicine The correct dosage of Lipisafe F depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Lipisafe F is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Lipisafe F is used -
Severe
Is the use of Lipisafe F safe for pregnant women?
Lipisafe F may have some side effects during pregnancy. Pregnant women should discontinue the use of Lipisafe F, and talk to their doctor, if they notice any discomfort.
Is the use of Lipisafe F safe during breastfeeding?
Lipisafe F can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Lipisafe F on the Kidneys?
There may be some adverse effects on kidney after taking Lipisafe F. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Lipisafe F on the Liver?
Lipisafe F has very mild side effects on the liver.
What is the effect of Lipisafe F on the Heart?
No research work has been carried out till date on effects of Lipisafe F on heart. So it is not known whether taking Lipisafe F will cause side effects on heart or not.
Lipisafe F should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Lipisafe F unless your doctor advises you to do so -
Is this Lipisafe F habit forming or addictive?
No, there is no any evidence that Lipisafe F is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Lipisafe F will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Lipisafe F should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Lipisafe F for mental disorders.
Interaction between Food and Lipisafe F
Taking Lipisafe F with food does not harm your health.
Interaction between Alcohol and Lipisafe F
Consumption of alcohol and Lipisafe F together may have severe effects on your health.
Lipisafe F comes in form of a tablet and ideally, it should be taken by mouth once daily as advised by your doctor. It can be taken with food or without food at any time of the day. Precautions must be taken in patients with liver disease, diabetes, and hypothyroidism.
Lipisafe F is a brand name of atorvastatin which belongs to the class of drugs known as statins (dyslipidemic agents). It is a prescription drug that is used for the treatment of mixed dyslipidemia (high levels of lipids in the blood), hypercholesterolemia (high cholesterol levels), and hypertriglyceridemia.
No, Lipisafe F should not be discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine.
It has been reported to cause weight gain but only in a few cases, this occurs very rarely. However, the exact cause behind this is unknown. if you notice any unusual weight gain after taking this drug. Then you are recommended to discuss it with your doctor.
Yes, Lipisafe F can be taken with ibuprofen. No harmful drug interaction has been reported between them. However, if you feel any discomfort after taking ibuprofen do not hesitate to inform your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lipitor® (Atorvastatin Calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 637-638
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
